Biodetectors And Accessories Market Size is projected to observe notable traction from 2022 to 2028 due to the escalating pollution levels and increasing burden of airborne diseases. The intensifying environmental degradation trend has given way to favorable government initiatives and awareness campaigns, generating multiple market growth opportunities. The higher threat of cardiovascular diseases, arsenicosis, cancers, and chronic kidney ailments will also enhance the industry outlook.
Biodetectors are analytical devices that mainly combine the precision as well as selectivity of biological solutions with the processing power of microelectronics, while accessories mark extensive presence in the detection of hazardous chemical agents and pathogens. The surging obligation to prevent bioterrorism and thriving need for technologically superior detection systems for the early recognition of potential biothreats will add to the biodetectors and accessories market growth.
However, the inadequate awareness in under-developed economies and higher costs of procuring the bio detector systems might hinder the industry progression to some extent.
Demand for biodetectors and accessories in clinical applications will rise through 2028 owing to the thriving need for detecting biomarkers, toxins, illicit drugs, and pathogens. The growing focus of medical practitioners on safe and cheaper ways of performing their research, while ensuring public safety, and offering customized health options to patients is another prominent trend impacting the biodetectors and accessories market expansion. Significant strides in biomedical studies of diagnosis and increasing number of DNA analysis will further augment the product penetration.
With regards to end-use, the point of care testing segment will bring significant revenue share for the industry owing to increasing penetration in rapid medical diagnosis and drug toxicology studies. The use of biodetectors and accessories in point-of-care testing helps in quick detection of analytes near to patients and better disease diagnosis, monitoring, and management. The growing efforts initiated by leading biodetectors and accessories market players to come up with portable, compatible, scalable, and reliable bioanalytical devices along with increasing popularity of Point-of-care (POC) biosensors in the rapid diagnosis of COVID-19 will add to the industry expansion. The rising bioterrorism threat levels and surging number of R&D investments are other factors driving the market growth.
North America is anticipated to witness higher consumption of biodetectors and accessories due to the increasing number of government initiatives for reinforcing counter-terrorism and homeland security. The growing air pollution levels have made way for higher technological advancements and increased burden of various chronic diseases. Robust presence of key industry players along with the escalating healthcare expenditure has resulted in the surging number of R&D investments and product launches. The increasing threat of contact diseases, including Ebola as well as growing government emphasis on enhancing biosecurity and higher availability of a well-developed infrastructure, will favor the market progression.
Some of the key biodetectors and accessories market players comprise BBI Detection, Research International (WPP plc, Kantar Group), BioDetection Systems, Shimadzu, Smith Detection (Smiths Group), Bertin, MSA, PositiveID, BioDetection Instruments, Response BioMedical, Thermo Fisher Scientific, NetBio, Physical Sciences, MBio Diagnostics, Bio Rad Laboratories, and Agilent Technologies.
Strategic team-ups, such as acquisitions, partnerships, and mergers along with new product launches and production expansions are increasingly adopted by these companies to increase their competitive value and broaden their geographical presence.
For instance, in August 2019, Agilent Technologies Inc. launched a multimode RTCA (real-time cell analyzer), a first of its kind that combines the best of non-invasive biosensor measurement solutions with live-cell imaging.
In response to the present COVID-19 crisis, the market demand for biodetectors and accessories significantly soared with increase in regulatory support towards preventive measures and initiating clinical urgency for procuring biodefense mechanisms. The growing weightage on innovations and researchers by key market players to limit the infection spread also pushed the market expansion. For instance, in February 2021, Smiths Detection came up with BioFlash®, a biological identifier that is capable of detecting SARS-CoV-2 virus in the air following tests performed by the USAMRIID (United States Army Medical Research Institute of Infectious Diseases).
Market, by Product Type
Market, by Medical Application
Market, by End-use
The above information is provided for the following regions and countries: